advertisement

EVToday Banner

September 2009


In This Issue:
Transcatheter Valve Therapies

Current valve repair techniques and technology that will affect your practice.

CHIEF MEDICAL EDITOR'S PAGE Transcatheter Valve Therapies By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

CHALLENGING CASES Abrupt Vessel Closure A detailed look at the intraprocedural decision making required to handle this challenging presentation. By Srihari S. Naidu, MD; David Choi, DO; and Peter Angelopoulos, MD

VASCULAR CLOSURE UPDATE The Two Sides of Vascular Access and Closure Part 1: Debating the pros and cons of manual compression versus vascular closure devices. By Zoltan G. Turi, MD

Closure and Assisted Compression Devices

TODAY'S PRACTICE Economic Benefits of the Transradial Approach How cost savings associated with the transradial approach might affect your percutaneous coronary interventions. By Sumeet Subherwal, MD, and Sunil V. Rao, MD

COVER STORY Self-Expanding Percutaneous Aortic Valve Implantation An update on the CoreValve system. By Hasan Jilaihawi, BSc, MB Chb, MRCP, and Raoul Bonan, MD

Balloon-Expandable Transcatheter Aortic Valve Implantation How the Edwards Sapien valve is changing the treatment of aortic stenosis. By Uygar C. Yuksel, MD; Samir R. Kapadia, MD; and E. Murat Tuzcu, MD

Transapical Transcatheter Aortic Valve Implantation Early results reveal successful implantation rates in patients with aortic stenosis. By John C. Alexander, MD, and Subhasis Chatterjee, MD

Current Status of Percutaneous Mitral Repair Using the MitraClip System Growing experience with this first-in-class device suggests it will have an important role in treating patients with mitral regurgitation. By Michael J. Rinaldi, MD, FACC, FSCAI; Gale Schwarz, RN, CCRC; and Geoffrey Rose, MD, FACC, FASE

European Perspective of Percutaneous Mitral Leaflet Repair An overview of the EVEREST trials and the MitraClip system used to treat mitral regurgitation. By Olaf Franzen, MD; Sven Meyer, MD; Stephan Baldus, MD; Anjelika Costard-Jäckle, MD; and Thomas Meinertz, MD

Next-Generation Percutaneous Mitral and Tricuspid Valve Repair Approaches What's next for transcatheter management of mitral and tricuspid valve disease. By Thomas W. Smith, MD; Steven F. Bolling, MD; and Jason H. Rogers, MD

Coronary Sinus Annuloplasty for Mitral Regurgitation A look at several devices with the ability to reduce functional mitral regurgitation. By Steven L. Goldberg, MD

The Next Generation of Transcatheter Aortic Valve Devices Which new technologies will become the gold standard for treating aortic valve disease? By Peter C. Block, MD

Transcatheter Mitral Valve Implantation The advantages of MIS-tMVI may make it the ideal choice for high-risk patients. By Howard C. Herrmann, MD

Percutaneous Pulmonary Valve Implantation An overview of percutaneous options for repair of the pulmonic valve. By Timothy D. Smith, MD; Clifford J. Kavinsky, MD, PhD, FACC; and Ziyad M. Hijazi, MD, MPH, FSCAI, FACC

FEATURED TECHNOLOGY Innovative Devices in Vascular Access Management A review of the Cardiva Catalyst™ II and III vascular closure devices. By Aravinda Nanjundappa, MD, FACC, FSCAI, RVT; and Robert S. Dieter, MD, RVT, FACC, FSVM

DEPARTMENTS Innovations

An Interview With Issam D. Moussa, MD Dr. Moussa shares what he believes is the way to generate and transfer new knowledge in the interventional cardiology community and explains why decision-making workshops such as CICT are important. By Issam D. Moussa, MD

Download a PDF of this supplement

CONTENTS Principles of Impella Cardiac Support The evolution of cardiac support technology toward the ideal assist device. By David M. Weber, PhD; Daniel H. Raess, MD, FACC, FACS; José P.S. Henriques, MD, PhD; and Thorsten Siess, PhD

A Case of Percutaneous Coronary Intervention for Acute Myocardial Infarction Infarction cardiogenic shock supported by the Impella device. By Arthur Grant, MD, FACC, FAHA, FSCAI, and Zehra Jaffrey, MD

Invited Commentary By Daniel H. Raess, MD, FACC, FACS - Abiomed Medical Director

A Pressure Wire Study on the Effect of Impella 2.5 Support How this device benefits coronary hemodynamics during high-risk angioplasty. By Salman A. Arain, MD, FACC, and Lawrence O'Meallie, MD, FACC